The Development of Novel Targeted Therapeutics for the Treatment of Multiple Myeloma

Objectives
Explores the latest research findings in targeted therapeutics for the treatment of multiple myeloma, critical for uncovering links to more effective and safer myeloma therapies.

Chairs
Kenneth C. Anderson, MD
Director, Jerome Lipper Multiple Myeloma Center
Medical Director, Kraft Family Donor Center
Professor of Medicine,
Harvard Medical School
Dana-Farber Cancer Institute

Bart Barlogie, MD, PhD
Professor of Medicine
Director, Myeloma Institute for Research and Therapy
University of Arkansas for Medical Sciences

James R. Berenson, MD
Director, Multiple Myeloma and Bone Metastasis Program
Cedars-Sinai Medical Center

William S. Dalton, MD, PhD
Chief Executive Officer and Center Director
H. Lee Moffitt Cancer Center & Research Institute

Sponsors
CTI
Genta Incorporated
Celgene Corporation
Millennium Pharmaceuticals
Novartis Pharmaceuticals Corporation
Genentech
McCarty Cancer Foundation

Download Abstracts